The tuna industry is one of the main employment drivers in Mauritius. CNN looks at how the entire supply chain is combating the effects of overfishing in the Indian Ocean and the industry’s hopes for the future.
Mauritius Prime Minister Pravind Jugnauth at India-Mauritius joint statement said the Comprehensive Economic Cooperation and Partnership Agreement (CECPA) is far-reaching and should unleash new and expanded opportunities in trade, goods and services. "Comprehensive Economic Cooperation and Partnership Agreement is 1st of its kind, signed by India with an African country. It's far-reaching and should unleash new and expanded opportunities in trade, goods and services, investment, economic cooperation and technical assistance,"said Mauritius PM. He added, "As India seeks to step her vast and multilayered cooperation with African continent, for next edition of India-Africa forum Mauritius aspires to play greater role in these engagements as a gateway between India and Africa."
Maharashtra reported 67,123 fresh COVID cases, 56,783 discharges, and 419 deaths on April 17. While Maharashtra's capital reported 8,834 new COVID-19 cases, 6,617 discharges and 52 deaths in last 24 hours. On the other side, Karnataka today registered 17,489 new positive cases, 5,565 discharges and 80 deaths. Kerala also reported 13,835 new cases, 3654 recoveries and 27 deaths today. Meanwhile, Madhya Pradesh reported 11,269 new coronavirus cases, 6,497 recoveries, and 66 deaths in last 24 hours.
After a comparative lull for a few months, the Covid virus seems to have returned with much more virulence. India is detecting more than double the number of daily cases than seen during the peak last year. Meanwhile, mass gatherings like political rallies and the Kumbh Mela in Haridwar have added to worries. The government however, is still keeping vaccination limited to those aged 45 years and above. As pressure on the healthcare system increases, many state governments have claimed shortage of oxygen, vaccines, and key drugs. In this backdrop, Union health minister Harsh Vardhan joins Kumkum Chadha to analyse the situation so far, and shed light on the government's strategy going forward.
Credit: HT Digital Content Duration: 44:09Published
The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."
Union Health Minister Harsh Vardhan on April 14 said that COVID vaccines are in sufficient amount in the country and state governments need to deploy the doses at the vaccination centres in time. "There is no shortage of vaccines and Government of India gives vaccines to every state. It is job of states to provide doses to vaccination centres in time bound manner with meticulous planning," said Harsh Vardhan. He also said that production of Remdesivir, the anti-drug for COVID-19, has increased and strict actions will be taken against those who'll try to do black marketing of it.
In view of increased demand of Remdesivir, anti-viral drug for COVID-19, Government of India has decided to increase production, supply and reduce prices of the drug, said Union Chemicals and Fertilisers Minister Mansukh Mandaviya. "GoI has decided to increase production, supply and reduce prices of Remdesivir drug. This will ramp up production capacity for manufacturing to around 80 lakh vials/month. The manufacturers of Remdesivir to reduce price to less than Rs 3500 by end of this week," said Union Chemicals and Fertilizers Minister, Mansukh Mandaviya. Remdesivir is considered as a key anti-viral drug in the fight against COVID-19, especially in adult patients with severe complications.